Reviewing the mechanism of action and results of clinical studies on the antifungal drug ibrexafungerp
Introduction. Vulvovaginal candidiasis is an extremely common pathology of the female genital organs, leading to a long-term recurrent course and multiple complications. Although currently it is widely known about developing antibiotic resistance of bacterial pathogens, it is necessary to remember a...
Saved in:
Main Authors: | L. I. Tagirova (Author), K. R. Farvazova (Author), D. R. Valeeva (Author), M. D. Orlova (Author), I. A. Gubaidullin (Author), A. M. Tulyabaeva (Author), A. R. Abdulmanova (Author), R. V. Tryapko (Author), D. A. Shelyginsky (Author), A. R. Khanafieva (Author), N. G. Semenova (Author), E. M. Takiullin (Author) |
---|---|
Format: | Book |
Published: |
IRBIS LLC,
2024-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ibrexafungerp: A Novel Oral Triterpenoid Antifungal in Development for the Treatment of <i>Candida auris</i> Infections
by: Mahmoud Ghannoum, et al.
Published: (2020) -
Treatment of Recurrent Vulvovaginal Candidiasis With Ibrexafungerp
by: Leah M. Grant MD, et al.
Published: (2022) -
Ibrexafungerp for the Treatment of Vulvovaginal Candidiasis: Design, Development and Place in Therapy
by: Phillips NA, et al.
Published: (2023) -
Repurposing therapy of ibrexafungerp vulvovaginal candidiasis drugs as cancer therapeutics
by: Tedi Rustandi, et al.
Published: (2024) -
Antifungal Action of Some Natural Oils on Acrylic Resin Denture Base Materials
by: Rana R AL- Sumaidae
Published: (2012)